Trial Profile
Retrospective observational study of favipiravir in patients with Ebola virus disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Feb 2019
Price :
$35
*
At a glance
- Drugs Favipiravir (Primary)
- Indications Ebola virus infections
- Focus Therapeutic Use
- 26 Feb 2019 New trial record
- 12 Feb 2019 Results published in the Journal of Infectious Diseases